Safety and Feasibility of Same-Admission Transcarotid Arterial Revascularization Prior to Heart Surgery for Patients Presenting With Concurrent, Severe Carotid Artery Stenosis, and Surgical Cardiac Disease. (PubMed, HCA Healthc J Med) - Mar 11, 2026 - "Bridging anticoagulation treatment included aspirin and either heparin infusion (60.0%, n = 9), intravenous antiplatelet therapy such as cangrelor or eptifibatide (33.33%, n = 5), or subcutaneous enoxaparin (6.67%, n = 1). In our experience, a range of anticoagulation bridging therapies did not result in apparent stent thrombosis and can be employed until the cardiac surgeon deems it safe to initiate oral dual antiplatelet therapy. Further studies with larger datasets are required to support the broader adoption of TCAR prior to heart surgery in patients with concurrent, severe cardiac and carotid disease."
Journal • Anesthesia • Cardiovascular • Coronary Artery Disease • Heart Failure • Hematological Disorders • Myocardial Infarction • Thrombosis
|
|
Bradley Boone; Brittany Landavazo; Chandler Vernon; David Nation; Jeffrey Apple; Kofi Quaye; Matthew D Kenny; Nicolas Zea; Ryan S Turley; Shir Yelovitch
|